2018 HEADLINES- Archives -
Top story: FDA approves first drug to use RNA interference, based on discoveries made at UMass Medical School
The new drug, patisiran, approved Aug. 10 by the FDA, is based on the discovery of RNAi made by Craig Mello, PhD, and Andrew Fire, PhD. It was developed by Alnylam, an RNAi-based drug development company co-founded by Phillip Zamore, PhD.
The annual U.S. News & World Report rankings of the best graduate schools names UMass Medical School in the top 10 percent nationwide in primary care, coming in 14th among 144 medical schools and 33 schools of osteopathic medicine surveyed by the weekly news magazine in its 2019 edition of the “Best Graduate Schools.”
Top story: UMass Medical School scientists safely deliver RNAi-based gene therapy for ALS in animal model
A gene therapy delivered to motor neurons was able to silence SOD1 protein, mutations of which are linked to ALS, without causing any adverse effects, according to a new study published in Science Translational Medicine, by Christian Mueller, PhD, and Robert H. Brown Jr., DPhil, MD.
Top story: UMass Medical School researchers explain why cannabis may relieve intestinal inflammation
Beth McCormick, PhD, led a study that has for the first time identified a biological mechanism to explain why some marijuana users have reported beneficial effects from cannabis on conditions such as ulcerative colitis and Crohn’s disease.
John E. Harris, MD, PhD, and colleagues have made a promising discovery that could lead to therapies for vitiligo with longer-lasting effects, according to new research published in Science Translational Medicine on July 18.
UMass Medical School geriatrics expert Jennifer Tjia, MD, MSCE, has been named a fellow of the American Academy of Hospice and Palliative Medicine in recognition of her dedication to and scholarship in the field.
A United States Army Special Forces soldier from Massachusetts who died in Afghanistan last month has been identified as the son-in-law of Barry Feldman, PhD.
The single-minded goal of cardiologist and scientist Jane Freedman, MD, is to seek insights that will help heal patients with heart disease. Learn about her research and career in the latest Women in Science video.
Daniel Lasser, MD, received the 2018 Distinguished Career Award and Erik Garcia, MD, was recognized with this year’s A. Jane Fitzpatrick Community Service Award from the Worcester District Medical Society.
The Winter Ball, the premier fundraising gala supporting the mission of the academic health sciences center formed by UMass Memorial Medical Center and UMass Medical School, reached its $2 million goal this year.